Pyxis Oncology Inc. (PYXS)
NASDAQ: PYXS
· Real-Time Price · USD
1.20
-0.01 (-0.83%)
At close: Jun 17, 2025, 11:51 AM
-0.83% (1D)
| Bid | 1.19 |
| Market Cap | 74.03M |
| Revenue (ttm) | 3.4M |
| Net Income (ttm) | -95.23M |
| EPS (ttm) | -1.61 |
| PE Ratio (ttm) | -0.74 |
| Forward PE | -1 |
| Analyst | Buy |
| Ask | 1.2 |
| Volume | 71,051 |
| Avg. Volume (20D) | 479,207 |
| Open | 1.20 |
| Previous Close | 1.21 |
| Day's Range | 1.17 - 1.22 |
| 52-Week Range | 0.83 - 5.39 |
| Beta | 1.18 |
About PYXS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PYXS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PYXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-5.83%
Pyxis Oncology shares are trading higher after the...
Unlock content with
Pro Subscription
6 months ago
-45.03%
Pyxis Oncology shares are trading lower after William Blair downgraded the stock from Outperform to Market Perform.
